Oct 14, 2025BoardMeeting
BoardMental Health Medication Advisory Committee Meeting Minutes
The committee reviewed and approved changes to antipsychotic medication criteria regarding Erzofri, Vraylar, and Cobenfy. The committee denied proposed criteria changes for Lybalvi due to concerns regarding prescribing and monitoring requirements. Additionally, the committee discussed the KSKidsMAP program, focusing on concerns related to inappropriate antipsychotic prescribing in children and adolescents and the misuse of pharmacogenomic testing.